<code id='9F8DDADAE7'></code><style id='9F8DDADAE7'></style>
    • <acronym id='9F8DDADAE7'></acronym>
      <center id='9F8DDADAE7'><center id='9F8DDADAE7'><tfoot id='9F8DDADAE7'></tfoot></center><abbr id='9F8DDADAE7'><dir id='9F8DDADAE7'><tfoot id='9F8DDADAE7'></tfoot><noframes id='9F8DDADAE7'>

    • <optgroup id='9F8DDADAE7'><strike id='9F8DDADAE7'><sup id='9F8DDADAE7'></sup></strike><code id='9F8DDADAE7'></code></optgroup>
        1. <b id='9F8DDADAE7'><label id='9F8DDADAE7'><select id='9F8DDADAE7'><dt id='9F8DDADAE7'><span id='9F8DDADAE7'></span></dt></select></label></b><u id='9F8DDADAE7'></u>
          <i id='9F8DDADAE7'><strike id='9F8DDADAE7'><tt id='9F8DDADAE7'><pre id='9F8DDADAE7'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:4
          An AstraZeneca sign at ESMO in Madrid.
          An AstraZeneca ad at ESMO 2023 in Madrid. Andrew Joseph/STAT

          MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months.

          On Monday, data presented here from a trial of the drug in advanced non-small cell lung cancer provided at least a fuller look. While the results assuaged some of the safety fears that flared when initial information was released over the summer, they only heightened concerns about the drug’s ability to outperform standard chemotherapy — though they perhaps pointed to an opportunity for the drug in a subset of patients.

          advertisement

          The trial, detailed here in a prime session at the annual meeting of the European Society for Medical Oncology, is testing a therapy called datopotamab deruxtecan, or Dato-DXd, in advanced or metastatic non-small cell lung cancer in patients who already tried at least first-line treatments. Patients were randomized to either receive chemotherapy or Dato-DXd, which AstraZeneca is developing with Daiichi Sankyo.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more
          The most pressing bird flu mysteries scientists want answered
          The most pressing bird flu mysteries scientists want answered

          Illustration:ChristineKao/STAT;Photos:Getty,Adobe,AP,CDCandNIAIDTenweeksaftergovernmentscientistsdis

          read more
          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more

          Lab trade group sues FDA to halt regulation of lab

          Thesuit,filedinaTexasfederalcourtbytheAmericanClinicalLaboratoryAssociationandPCRlabHealthTrackRx,cl